• BioAscent Introduces the Compound Connect Interface to Connect Drug Discovery Customers wi... 11/2/2022
• BioAscent Reports Third Year of High Double-digit Growth 12/20/2021
• BioAscent’s Compound Management Services Prove Stellar Success with Biotech Companies 10/22/2021
• BioAscent Enhances its Computational Chemistry Services 5/6/2021
• BioAscent Reports Significant Growth in Discovery Services Business 1/15/2021
• BioAscent Invests ￡1m to Expand Drug Discovery Service Offering 9/4/2020
• BioAscent Appoints Nick Moore, PhD to Steer Growth in US 6/24/2020
• Successful Partnership Between MolPort and BioAscent Reaches 100-project Milestone 5/27/2020
• BioAscent Scientists Help Identify Potential New Treatments for Cancer 12/17/2019
• BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth 9/10/2019
• BioAscent Records Successful First Year as Fully Integrated Discovery Services CRO 6/21/2019
• BioAscent Secures Investment to Expand its Integrated Drug Discovery Services 6/28/2018
• XenoGesis and BioAscent collaborate to offer enhanced integrated drug discovery services 5/17/2018
• Merz outsources its compound management to BioAscent 3/3/2017